Ir para o conteúdo principal

United States News Todas as matérias

Todas as matérias desta seção, das mais recentes às mais antigas — página 215 de 371.

Grafa

Moderna initiates Phase 3 trial for H5 pandemic flu vaccine to bolster global readiness

Moderna (NASDAQ:MRNA) announced a significant milestone in global health security on April 22, 2026, with the dosing of the first participants in the United States and the United Kingdom for its Phase 3 clinical trial of mRNA-1018.

Leia mais: Moderna initiates Phase 3 trial for H5 pandemic flu vaccine to bolster global readiness
Grafa
Technology

Kemper sells Newins distribution operation to Confie to sharpen specialty focus

Kemper (NYSE:KMPR) announced today that it has completed the sale of its property and casualty distribution operation, which includes captive agents and storefront locations, to Confie, a leading national insurance distribution company.

Leia mais: Kemper sells Newins distribution operation to Confie to sharpen specialty focus
Grafa

Peoples Bancorp to expand Kentucky footprint via $76.6M acquisition of Citizens National

Peoples Bancorp (NASDAQ:PEBO), the parent company of Peoples Bank, announced today that it has entered into a definitive merger agreement to acquire Citizens National in a transaction valued at approximately $76.6 million.

Leia mais: Peoples Bancorp to expand Kentucky footprint via $76.6M acquisition of Citizens National
Grafa

Merck and Eisai triplet therapy fails to improve survival in kidney cancer trial

Merck (NYSE:MRK) Eisai announced today that their Phase 3 LITESPARK-012 trial failed to meet its dual primary endpoints, a disappointing result for the pharmaceutical partners’ attempt to establish a new standard of care in first-line kidney cancer treatment.

Leia mais: Merck and Eisai triplet therapy fails to improve survival in kidney cancer trial